Draft Guidance Webinar: FDA/CBER’s Consensus Standards Recognition Program

Don't miss this opportunity to be heard. The Standards Coordinating Body for Regenerative Medicine (SCB) will be hosting a two-hour Webinar on August 24, 2022, at 12:00 pm EST to discuss the recently released FDA guidance on CBER's Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies.  In this webinar, SCB will explain the draft guidance […]

BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.




Learn more about work underway to build the biofabrication ecosystem and accelerate the science of regenerative medicine.